Clinical Trials Browser

OTHER × Recurrence × durvalumab × Clear all

NCT03999710 2025-11-28

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Recurrence

NCT03723967 2024-04-22

FRAIL-IMMUNE

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT04015739 2022-08-17

BOLD

Phase 2 Unknown

Carcinoma, Ovarian Epithelial, Recurrence

NCT03799744 2022-03-28

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

Phase 1 Unknown

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence